Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies
Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 4
Abstract
The advancement of therapeutic monoclonal antibodies during various stages of the drug development process can be effectively streamlined when appropriate translational strategies are applied. Design of successful translational strategies for development of monoclonal antibodies should allow for understanding of the dose– and concentration–response relationships with respect to both beneficial and toxic effects from early phases of drug development. Evaluation of relevant biomarkers during early stages of drug development should facilitate the successful design of safe and effective dosing strategies. Moreover, application of quantitative pharmacology is critical for translation of exposure–response relationships early on.
Authors and Affiliations
Mohammad Tabrizi, Cherryl Funelas, Hamza Suria
Keywords
Related Articles
- EP ID EP681408
- DOI 10.1208/s12248-010-9220-2
- Views 88
- Downloads 0
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9
The online version of this article (doi:10.1208/s12248-015-9750-8) contains supplementary material, which is available to authorized users.
Synthesis and characterization of positively charged tPA as a prodrug using a heparin/protamine-based drug-delivery system
Positively charged peptides [(Arg)-Cys] were sucessfully linked to tissue-specific plasminogen activator (tPA) using cross-linking agent N-succinimidyl 3-(2-pyridyldithio) propionate. Specific amidolytic activity of this...
Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators
The review summarizes the most recent achievements in structure–activity relationship (SAR) studies of tariquidar and its analogs. Tariquidar is one of the most promising representatives of the third generation o...
The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model
The presence of halogens within the classical cannabinoid structure leads to large variations in the compounds' potencies and affinities for the CB1 receptors. To explore the structure activity relationships within this...
Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling
Our ultimate goal is to develop mechanism-based pharmacokinetic (PK)-pharmacodynamic (PD) models to characterize and to predict CNS drug responses in both physiologic and pathologic conditions. To this end, it is essenti...